Procurement Summary
Country: Japan
Summary: Epoc2504 Study: Establishment and Maintenance of Allocation and Edc Coordination Functions in a Randomized Phase Ii Study to Examine the Efficacy, Safety, and Proof of Concept of S-531011 Monotherapy and S-531011 + Pembrolizumab in Post-Curative R...
Deadline: 01 Jul 2026
Posting Date: 17 Jun 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 143439624
Document Ref. No.:
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
EPOC2504 study: Establishment and maintenance of allocation and EDC coordination functions in a randomized phase II study to examine the efficacy, safety, and proof of concept of S-531011 monotherapy and S-531011 + pembrolizumab in post-curative resection colorectal cancer patients with positive circulating tumor DNA. Description: EPOC2504 study Efficacy, safety, and Proof of Concept of S-531011 monotherapy and S-531011 + pembrolizumab in patients with curatively resected colorectal cancer who are positive for circulating tumor DNA... Deadline: 2026-07-01 [Disclaimer: This notice does not specify a specific deadline, so we have added 15 days from the date of posting]
Documents
Tender Notice